CACNA1A and spinocerebellar ataxia type 6: Therefore, in this cohort of patients, reduced after-effect can be used to separate pre-clinical SCA6 individuals with cerebellar dysfunctions from non-SCA6 control participants, even though these individuals display no or minimum overt clinical symptoms.